Status of vaccine research and development for enterotoxigenic Escherichia coli

Agriculture & Biology

• enterotoxigenic Escherichia coli 100%
• research and development 76%
• vaccines 63%
• vaccine development 27%
• antigens 16%
• cost effectiveness 15%
• public health 13%
• child health 11%
• antitoxins 10%
• toxoids 10%
• econometric models 9%
• adhesins 9%
• World Health Organization 9%
• funding 8%
• Bangladesh 8%
• morbidity 7%
• protein subunits 7%
• diarrhea 7%
• developing countries 7%
• vaccination 6%
• immunity 6%
• markets 5%
• economics 4%
• uptake mechanisms 4%
• antibodies 4%
• proteins 2%

Medicine & Life Sciences

• Enterotoxigenic Escherichia coli 98%
• Escherichia coli Vaccines 69%
• Vaccines 55%
• Antigens 15%
• Cost-Benefit Analysis 14%
• Toxoids 12%
• Public Health 11%
• Antitoxins 11%
• Combined Vaccines 11%
• Economic Development 10%
• Health Priorities 10%
• Bangladesh 9%
• Protein Subunits 9%
• Point-of-Care Systems 9%
• Insurance Benefits 8%
• Health 7%
• Developing Countries 7%
• Health Care Costs 7%
• Diarrhea 6%
• Immunity 6%
• Vaccination 6%
• Morbidity 4%
• Antibodies 4%
• Mortality 4%
• Child 3%
• Proteins 3%

Social Sciences

• research and development 66%
• diagnostic 20%
• candidacy 18%
• public health 17%
• economic model 14%
• immunity 13%
• costs 13%
• vaccination 13%
• Child health 12%
• morbidity 12%
• Bangladesh 12%
• WHO 11%
• health 11%
• mortality 10%
• infant 10%
• developing country 9%
• demand 8%
• cause 7%
• market 6%
• economics 5%